FDA Global Health Fellowship
*Applications will be reviewed on a rolling-basis. Early submission of applications is strongly encouraged. A selection may be made at any time during the review process.
Three opportunities are available at the U.S. Food and Drug Administration (FDA), Office of the Commissioner (OC), Office of Global Policy and Strategy (OGPS) located in Silver Spring, Maryland.
The Office of Global Policy and Strategy covers all regulated commodities that are imported into the United States from a policy perspective, and the program office is seeking two participants to perform global health and regulatory analysis on topics including:
- Qualitative and quantitative analysis on how the agency can best leverage multilateral institutions such as the WHO, PAHO, OECD, ASEAN, and APEC to advance the agencies public health priorities
- In-depth analysis on FDA's regulatory programs and strategies on how domestic health policy priorities such as health equity and response to Long Covid could be amplified in the global arena
- Identify areas where OGPS global work overlaps functional units, and develop policy positions and presentations that can be used across the organization
Expected learning objectives for the participant include:
- Learn to develop public health policy in the global context
- Learn through a thorough analysis global regulatory best practices and guidelines
Anticipated Appointment Start Date: September 21, 2021; start date is flexible
This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. A health insurance allowance will be provided, and an allowance for relocation expenses are also available. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in the Silver Spring, Maryland, area. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.
If you have questions, send an email to ORISE.FDA.OC.other@orau.org. Please include the reference code for this opportunity (FDA-OGPS-2021-06) in your email.